CARE Ratings (CARERATING) Q1 25/26 earnings summary

Executive summary

• Operating income grew 16% year-over-year to Rs. 75.6 Crs standalone and 19% to Rs. 93.9 Crs consolidated.

• Board approved unaudited standalone and consolidated financial results for the quarter ended June 30, 2025, and reappointed two independent directors for three-year terms, subject to shareholder approval.

• Limited review reports from statutory auditors confirm no material misstatements in both standalone and consolidated results.

• EBITDA margin improved to 36% standalone and 30% consolidated, with PAT margins at 32% and 25% respectively.

• EPS reached Rs. 9.72 standalone and Rs. 8.61 consolidated for Q1 FY26.

Financial highlights

• Standalone EBITDA rose 23% year-over-year to Rs. 27.2 Crs; consolidated EBITDA up 36% to Rs. 27.8 Crs.

• Consolidated revenue from operations for Q1 FY25-26 was ₹9,390.50 lakhs, up from ₹7,892.00 lakhs in Q1 FY24.

• Standalone PAT increased 21% to Rs. 29.1 Crs; consolidated PAT up 24% to Rs. 26.5 Crs.

• Basic EPS (consolidated) for Q1 FY25-26 was ₹8.61, up from ₹6.94 in Q1 FY24.

• Standalone revenue from operations for Q1 FY25-26 was ₹7,563.93 lakhs, up from ₹6,534.35 lakhs in Q1 FY24.

Outlook and guidance

• Continued government focus on capex expected to sustain investment growth, with capex-to-GDP budgeted at 3.1% for FY26.

• Healthy GST collections and PMI levels indicate ongoing economic expansion.

• Board and audit committee reviewed and approved results, with no adverse findings from auditors, supporting continued operational stability.